It was recently granted orphan drug status and apparently there is a Finnish phase 1 trial.
Here is an article about an early trial:
http://www.ncbi.nlm.nih.gov/pubmed/23493351
It sounds interesting.
It was recently granted orphan drug status and apparently there is a Finnish phase 1 trial.
Here is an article about an early trial:
http://www.ncbi.nlm.nih.gov/pubmed/23493351
It sounds interesting.